Domov › Nemalicelični pljučni rak › Florida › Deltona
Klinične študije za Nemalicelični pljučni rak v Deltona, FL
15 študij za Nemalicelični pljučni rak išče udeležence na lokacijah v Deltona in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
Vključevanje udeležencevFaza 1/2
- Mid Florida Hematology And Oncology Center /ID# 273777, Orange City · 4 mi stran
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Vključevanje udeležencevFaza 3
- Mid Florida Hematology and Oncology Center ( Site 0018), Orange City · 4 mi stran
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Alpha Clinical Research Centers LLC, Orange City · 4 mi stran
- Florida Cancer Specialists, Orange City · 4 mi stran
- Mid Florida Hematology and Oncology Center, Orange City · 4 mi stran
- in še 1
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Vključevanje udeležencevFaza 3
- Mid Florida Hematology and Oncology Center, Orange City · 4 mi stran
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
Vključevanje udeležencevFaza 1/2
- Mid Florida Hematology and Oncology Center, Orange City · 4 mi stran
Pan-tumor MRD Study
Vključevanje udeležencevOpazovalna študija
- Mid Florida Cancer Centers, Orange City · 4 mi stran
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Vključevanje udeležencevFaza 3
- Research Site, Orange City · 4 mi stran
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Vključevanje udeležencevFaza 3
- Mid Florida Hematology and Oncology Center, Orange City · 4 mi stran
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Vključevanje udeležencevFaza 2/3
- Mid Florida Cancer Centers, Orange City · 4 mi stran
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
Vključevanje udeležencevFaza 3
- Mid Florida Hematology and Oncology Center, Orange City · 4 mi stran
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Vključevanje udeležencevFaza 2/3
- Local Institution - 007-926-B, Daytona Beach · 26 mi stran
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Mid-Florida Hematology & Oncology Centers, P.A., Orange City · 4 mi stran
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Research Site, Orange City · 4 mi stran
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Vključevanje udeležencevFaza 1/2
- Mid Florida Hematology and Oncology Center, Orange City · 4 mi stran
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
Vključevanje udeležencevFaza 2
- Mid Florida Hematology and Oncology Center, Orange City · 4 mi stran
Študije za Nemalicelični pljučni rak v drugih mestih
- Houston, TX145 študij
- New York City, NY121 študij
- Arlington, VA104 študij
- Nashville, TN97 študij
- Boston, MA90 študij
- Los Angeles, CA87 študij
- St. Louis, MO73 študij
- Chicago, IL61 študij
- Baltimore, MD60 študij
- San Antonio, TX59 študij
- Columbus, OH57 študij
- Washington, DC55 študij
Druge študije v Deltona
- Debelost11 študij
- Alzheimerjeva bolezen10 študij
- Sladkorna bolezen tipa 210 študij
- Prekomerna telesna teža9 študij
- Rak dojke8 študij
- Rak pljuč8 študij
- Rak (vse vrste)7 študij
- Metastatski rak5 študij
- BOPC5 študij
- Visok krvni tlak5 študij
- Melanom5 študij
- Artroza kolena5 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.